Schally, Guillemin and the neuropeptides controlling the adenohypophysis
Cover of our Vol. 11, Issue 2, 2024
PDF (Español (España))


Andrew Schally
Roger Guillemin
anterior pituitary gland
releasing hormones
inhibitory hormones
cancer therapy
diabetes treatment
history of medicine

How to Cite

Jácome Roca, A. (2024). Schally, Guillemin and the neuropeptides controlling the adenohypophysis. Revista Colombiana De Endocrinología, Diabetes &Amp; Metabolismo, 11(2).


Purpose: This narrative review seeks to build on and summarize the story of Andrew Schally and Roger Guillemin, who isolated, demonstrated their function and structure, and then synthesized the hypothalamic peptides that control the adenohypophysis. In an anecdotical way, I summarize my experience with the Tulane-VA endocrine group.

Content: The life and work of these researchers who were influenced during their apprenticeship by well-known figures in science, Harris and Selye among others are described. They worked together at first, but then separately (one at Tulane, the other at Baylor) in a decade of competitive research on hypothalamic hormones, the results of which led to their winning the Nobel Prize in Physiology or Medicine in 1977. In the two groups, there were important researchers that also made valuable investigations in neuropeptides.

Contributions: The studies of these two scientists, and the group of important collaborators who worked with them, began the production of neuropeptides and analogues that are fundamental in certain diagnostic processes or in therapeutics for many diseases, particularly diabetes and cancer.
PDF (Español (España))


Guillemin R. Purification, isolation, and primary structure of the hypothalamic luteinizing hormone-releasing factor of ovine origin. Am J Obst Gynecol. 1977;129(2):214-8.

The Nobel Foundation. Andrew V. Schally: Biographical. The Nobel Prize.

Schally AV. Aspects of hypothalamus regulation of the pituitary gland with major emphasis on its implications for the control of reproductive processes [lectura Nobel, 1977]. En: Lindsten J, editor. Nobel Lectures, Physiology or Medicine 1071-1980. Singapur: Word Scientific Publishing Co; 1992. p. 405-38.

Matsuo H, Baba Y, Nair RM, Arimura A, Schally AV. Structure of the porcine LH- and FSH-releasing hormone. I. The proposed amino acid sequence. Biochem Biophys Res Commun. 1971;43:1334-9.

Wade, N. Guillemin and Schally: A race spurred by rivalry. Science. 1978;200(4341):510-3.

Odelberg W. Les Prix Nobel. Estocolmo, Suecia: Nobel Foundation; 1978.

Guillemin R. Pioneering in Neuroendocrinology 1952-1969. En: Meites J, Donovan BT, McCann SM, editores. Pioneers in Neuroendocrinology II. Perspectives in Neuroendocrine Research, vol 2. Boston, Estados Unidos: Springer; 1978.

Guillemin R. Peptides of the brain. The new endocrinology of the neuron [lectura Nobel, 1977]. En: Lindsten J, editor. Nobel Lectures, Physiology or Medicine 1071-1980. Singapur: Word Scientific Publishing Co; 1992. p. 364-97.

Medvei VC. A history of endocrinology. Lancaster, Inglaterra: MTP Pr; 1982.

Jacome-Roca A. Historia de las hormonas. Bogotá: Academia Nacional de Medicina de Colombia; 2008.

Amaro-Méndez S. Breve historia de la endocrinología. La Habana: Editorial Científico-Técnica; 1975.

Roussy G, Mosinger M. Le systeme neuro-endocrinien. París: C. R. Soc Biol; 1933.

Harris GW. Neural control of the pituitary gland. Londres: Arnold; 1955.

Sawin CT. Geoffrey Harris and the brain’s control of the pituitary gland. Endocrinologist. 1988;8(2):117-22.

Plant TM. 60 years of neuroendocrinology: The hypothalamic-pituitary-gonadal axis. J Endocrinol. 2015;226(2):T41-54.

Jácome Roca A. Hans Selye y la endocrinología social. Rev Colomb Endocrinol Diab Metab. 2017;2(1):44-7.

Saffran M, Schally AV. The status of the corticotropin releasing factor (CRF). Neuroendocrinology. 1977;24(5-6):359-75.

Schally AV, Dupont A, Arimura A, Redding TW, Nishi N, Linthicum GL, et al. Isolation and structure of somatostatin from porcine hypothalami. Biochemistry. 1976;15(3):509-14.

Arimura A, Sato H, Dupont A, Nishi N, Schally AV. Somatostatin: abundance of immunoreactive hormone in rat stomach and pancreas. Science. 1975;189(4207):1007-9.

Brownstein M, Arimura A, Sato H, Schally AV. The regional distribution of somatostatin in the rat brain. Endocrinology. 1975;96(6):1456-61.

Schally AV, Arimura A, Kastin AJ. Hypothalamic regulatory hormones Science. 1973;179(4071):341-50.

Bloom SR, Mortimer CH, Thorner MO, Besser GM, Hall R, Gomez-Pan A, et al. Inhibition of gastrin and gastric-acid secretion by growth-hormone release-inhibiting hormone. Lancet. 1974;2(7889):1106-9.

Bøler J, Enzmann JF, Folkers K, Bowers CY, Schally AV. The identity of chemical and hormonal properties of the thyrotropin releasing hormone and pyroglutamyl-histidyl-proline amide. Biochem Biophys Res Commun. 1969;37(4):705-10.

Chang RC, Huang WY, Redding TW, Arimura A, Coy DH, Schally AV. Isolation and structure of several peptides from porcine hypothalami. Biochim Biophys Acta. 1980;625(2):266-73.

Schally AV, Redding TW, Bowers CY, Barrett JF. Isolation and properties of porcine thyrotropin-releasing hormone. J Biol Chem. 1969;244(15):4077-88.

Schally AV, Arimura A, Kastin AJ, Matsuo H. Gonadotropin-releasing hormone: one polypeptide regulates secretion of luteinizing and follicle-stimulating hormones. Science. 1971;173(4001):1036-8.

Schally AV, Arimura A, Baba Y, Nair RM, Matsuo H, Redding TW, et al. Isolation and properties of the FSH and LH-releasing hormone. Biochem Biophys Res Commun. 1971;43(2):393-9.

Schally AV, Comaru-Schally AM, Redding TW. Antitumor effects of analogs of hypothalamic hormones in endocrine-dependent cancers. Proc Soc Exp Biol Med. 1984;175(3):259-81.

Schally AV, Redding TW, Paz-Bouza JI, Comaru-Schally AM, Mathe G. Current concept for improving treatment of prostate cancer based on combination of LH-RH agonists with other agents. Prog Clin Biol Res. 1987;243A:173-97.

Schally AV, Srkalovic G, Szende B, Redding TW, Janaky T, Juhasz A, et al. Antitumor effects of analogs of LH-RH and somatostatin: experimental and clinical studies. J Steroid Biochem Mol Biol. 1990;37(6):1061-7.

Schally AV, Kastin AJ, Arimura A, Coy D, Coy E, Debeljuk L, et al. Basic and clinical studies with luteinizing hormone-releasing hormone (LH-RH) and its analogues. J Reprod Fertil Suppl. 1973;20:119-36.

Schally AV, Comaru-Schally AM, Nagy A, Kovacs M, Szepeshazi K, Plonowski A, et al. Hypothalamic hormones and cancer. Front Neuroendocrinol. 2001;22(4):248-91.

Schally AV. Oncological applications of somatostatin analogues. Cancer Res. 1988;48(24):6977-85.

Barss P. A.V. Schally. Boletín de la Universidad de McGill, Montreal, Canadá.

Louzada RA, Blandino-Rosano M, Flores S, Lubaczeuski C, Cui T, Sha W, Cai R, Schally AV, Bernal-Mizrachi E. GHRH agonist MR-409 protects ?-cells from streptozotocin-induced diabetes.Proc Natl Acad Sci U S A. 2023;20;120(25):e2209810120.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright (c) 2024 Revista Colombiana de Endocrinología, Diabetes & Metabolismo




Download data is not yet available.